中国卫生标准管理
中國衛生標準管理
중국위생표준관리
CHINA HEALTH STANDARD MANAGEMENT
2015年
14期
24-25
,共2页
肝动脉介入化疗栓塞%射频消融%肝癌
肝動脈介入化療栓塞%射頻消融%肝癌
간동맥개입화료전새%사빈소융%간암
Hepatic artery interventional chemotherapy embolism%Radiofrequency ablation%Cancer of liver
目的:探讨经皮肝动脉介入化疗栓塞与射频消融联合治疗中、晚期肝癌的临床效果。方法选择56例中晚期肝癌患者,将患者分为肝动脉介入化疗栓塞与射频消融联合治疗组(A组)及单纯肝动脉介入化疗栓塞组(B组),每组28人,经治疗后,定期复查患者,比较两组患者血清甲胎蛋白浓度、肿瘤复发率及生存率情况。结果 A组患者非细胞毒性免疫抑制因子(AFP)浓度下降率为72.0%;复发率:7.14%;1年、2年、3年生存率分别为:87.0%、63.8%、40.1%;B组患者AFP浓度下降率为53.2%;复发率:25.00%;1年、2年、3年生存率分别为:65.2%、42.7%、28.5%。结论肝动脉介入化疗栓塞联合射频消融比单纯肝动脉介入化疗栓塞在治疗肝癌疾病上更加安全有效。
目的:探討經皮肝動脈介入化療栓塞與射頻消融聯閤治療中、晚期肝癌的臨床效果。方法選擇56例中晚期肝癌患者,將患者分為肝動脈介入化療栓塞與射頻消融聯閤治療組(A組)及單純肝動脈介入化療栓塞組(B組),每組28人,經治療後,定期複查患者,比較兩組患者血清甲胎蛋白濃度、腫瘤複髮率及生存率情況。結果 A組患者非細胞毒性免疫抑製因子(AFP)濃度下降率為72.0%;複髮率:7.14%;1年、2年、3年生存率分彆為:87.0%、63.8%、40.1%;B組患者AFP濃度下降率為53.2%;複髮率:25.00%;1年、2年、3年生存率分彆為:65.2%、42.7%、28.5%。結論肝動脈介入化療栓塞聯閤射頻消融比單純肝動脈介入化療栓塞在治療肝癌疾病上更加安全有效。
목적:탐토경피간동맥개입화료전새여사빈소융연합치료중、만기간암적림상효과。방법선택56례중만기간암환자,장환자분위간동맥개입화료전새여사빈소융연합치료조(A조)급단순간동맥개입화료전새조(B조),매조28인,경치료후,정기복사환자,비교량조환자혈청갑태단백농도、종류복발솔급생존솔정황。결과 A조환자비세포독성면역억제인자(AFP)농도하강솔위72.0%;복발솔:7.14%;1년、2년、3년생존솔분별위:87.0%、63.8%、40.1%;B조환자AFP농도하강솔위53.2%;복발솔:25.00%;1년、2년、3년생존솔분별위:65.2%、42.7%、28.5%。결론간동맥개입화료전새연합사빈소융비단순간동맥개입화료전새재치료간암질병상경가안전유효。
Objective To study the clinical efficacy of the percutaneous hepatic artery interventional chemotherapy embolism with radiofrequency ablation treatmentin advanced liver cancer.Methods Fifty-six cases of middle-late liver cancer patients were divided into hepatic artery interventional chemotherapy embolism with radiofrequency ablation treatment group(group A)and simple hepatic artery interventional chemotherapy embolism group(group B),each group of 28 people,after treatment,serum concentration of AFP,tumor recurrence rate and survival rate were reviewed and compared.Results Patients in group A of AFP concentration decline rate was 72.0%,the recurrence rate 7.14%,1 year,2 years,3 years survival rate 87.0%,63.8%,40.1%,group B patients with AFP concentration decline rate was 53.2%. The recurrence rate 25.00%,1 year,2 years,3 years survival rate 65.2%,42.7%,28.5%.Conclusion The hepatic artery interventional chemotherapy embolism joint radiofrequency ablation is more safe and effective for the treatment of liver diseases.